Latest Behring Stories
Presentations focus on Hizentra flexible dosing regimens and push administration PRAGUE, Oct.
JNC is the Bleeding Disorders Community's Original Golf and Baseball Competition for Kids with Hemophilia and/or von Willebrand disease (VWD) and Their Families PHOENIX, Oct.
KING OF PRUSSIA, Pa., Oct.
CSL Plasma center openings are on the rise, as is the demand for plasma protein therapies for the treatment of rare and serious diseases. KING OF PRUSSIA, Pa., Oct.
Company further increases global manufacturing capabilities with production expansions of albumin in Australia and plasma intermediates in U.S.
The 140,000-square foot expansion has received regulatory approval from the U.S. Food & Drug Administration. KING OF PRUSSIA, Pa., Sept.
CSL Behring Assists The Jeffrey Modell Foundation and National Association of School Nurses to prepare an information blitz to improve early referral and diagnosis. KING OF PRUSSIA, Pa., Aug.
Eligible Participants to Receive Payment Assistance with Out-of-Pocket Costs Associated with Hizentra® Therapy in the United States KING OF PRUSSIA, Pa., May 20, 2014 /PRNewswire/
Third annual awareness day shines a light on rare, potentially life-threatening condition KING OF PRUSSIA, Pa., May 14, 2014 /PRNewswire/ -- As a Diamond Sponsor of HAE Day on May 16, 2014,
-- Leading-edge science at the core of $250 million expansion to drive long-term growth in promising bleeding disorders portfolio KING OF PRUSSIA, Pa., May 9, 2014 /PRNewswire/
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.